JNJ-18038683
Overview[edit | edit source]
JNJ-18038683 is a chemical compound that has been studied for its potential use in the treatment of various psychiatric disorders. It is known to act as a selective antagonist of the 5-HT7 receptor, which is a subtype of the serotonin receptor. The compound was developed by Johnson & Johnson and has been the subject of research in the field of neuropharmacology.
Chemical Structure[edit | edit source]
The chemical structure of JNJ-18038683 is characterized by its unique arrangement of atoms, which allows it to selectively bind to the 5-HT7 receptor. This specificity is crucial for its potential therapeutic effects, as it minimizes interaction with other receptor types, thereby reducing the likelihood of side effects.
Mechanism of Action[edit | edit source]
JNJ-18038683 functions primarily as an antagonist at the 5-HT7 receptor. The 5-HT7 receptor is involved in the regulation of various neurological processes, including circadian rhythm, mood, and cognition. By blocking this receptor, JNJ-18038683 may help modulate these processes, offering potential benefits in the treatment of disorders such as depression, anxiety, and schizophrenia.
Potential Therapeutic Applications[edit | edit source]
Research into JNJ-18038683 has suggested several potential therapeutic applications. Its ability to modulate the 5-HT7 receptor makes it a candidate for the treatment of mood disorders, where dysregulation of serotonin signaling is often implicated. Additionally, its effects on cognition and circadian rhythm suggest possible uses in treating cognitive impairments and sleep disorders.
Development and Research[edit | edit source]
The development of JNJ-18038683 is part of a broader effort by pharmaceutical companies to create more targeted therapies for psychiatric conditions. By focusing on specific receptor subtypes, researchers aim to develop drugs that are both effective and have fewer side effects compared to traditional treatments.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
